Phenylalkylaminoethylsalicylamide, its preparation and...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/550.8

C07C 233/00 (2006.01) A61K 31/60 (2006.01)

Patent

CA 1151211

ABSTRACT The (R,R) optical isomer of labetalol, namely 5-{ (R)- -l-hydroxy-2-[(R)-l-methyl-3-phenylpropyl)amino]ethyl} sali- cylamide, and its pharmaceutically acceptable acid addi- tion salts, in a state substantially free of the correspon- ding (R,S), (S,R) and (S,S) optical isomers, are novel com- pounds with favourable therapeutic properties in compari- son with labetalol. They can be used in particular in the treatment of hypertension. The novel (R,R) optical isomer and its pharmaceutically acceptable acid addition salts can be prepared by removal of the protecting groups from an N,O-protected (R,R) opti- cal isomer or acid addition salt thereof, wherein the ba- sic nitrogen atom and the phenolic hydroxy group are pro- tected, preferably by hydrogenolytic removal of hydrogeno- lysable groups.

335885

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Phenylalkylaminoethylsalicylamide, its preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylalkylaminoethylsalicylamide, its preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalkylaminoethylsalicylamide, its preparation and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-820147

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.